Vascular endothelial growth factor (VEGF) polymorphisms in HELLP syndrome patients determined by quantitative real-time PCR and melting curve analyses

Nagy, Balint; SAVLI, HAKAN; Molvarec, Attila; Varkonyi, Tibor; Rigo, Barbara; Hupuczi, Petronella; Rigo, Janos

doi:10.1016/j.cca.2007.12.003

Vascular endothelial growth factor (VEGF) polymorphisms in HELLP syndrome patients determined by quantitative real-time PCR and melting curve analyses

Atıf İçin Kopyala

Nagy B., SAVLI H., Molvarec A., Varkonyi T., Rigo B., Hupuczi P., ...Daha Fazla

CLINICA CHIMICA ACTA, cilt.389, ss.126-131, 2008 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 389
Basım Tarihi: 2008
Doi Numarası: 10.1016/j.cca.2007.12.003
Dergi Adı: CLINICA CHIMICA ACTA
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.126-131
Kocaeli Üniversitesi Adresli: Evet

Özet

Background: The vascular endothelial growth factor (VEGF) has a critical role in vasculogenesis and vascular permeability in several diseases including preeclampsia. There are at least 30 single nucleotide polymorphic (SNP) places on this gene. VEGF G+405C, C-2578A and C-460T SNPs are known to be related to VEGF production. VEGF polymorphisms were studied in preeclampsia, but not in HELLP syndrome. Therefore, we decided to determine the allele and genotype frequencies of VEGF G+405C, C-460T and C-2578A SNPs in healthy pregnant women and HELLP syndrome patients.